NICE Interaction Analytics Chosen by Tele-Centre Services to Drive Customer Experience Interactions (CXi) Transformation
NICE data-driven insights automate quality management and provide insights on both customer and agent behaviors…
NICE data-driven insights automate quality management and provide insights on both customer and agent behaviors…
DALLAS–(BUSINESS WIRE)–Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased…
HENDERSON, Nev.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth-enabled…
Major transparency milestone for the VPN company following audit by big four firm 30th August…
Möglingen, August 30, 2022. BWI GmbH, the IT systems company of the German Federal Armed…
Secured up to US$170m in non-dilutive financing Received commitments for well supported US$90m equity financing;…
KUALA LUMPUR, Aug 30, 2022 – (ACN Newswire) – PLS Plantations Berhad recorded a net…
NEW YORK & STAMFORD, Conn.–(BUSINESS WIRE)–Developing World Markets (“DWM”), a U.S.-based private equity and debt…
In an independent survey run on behalf of NHS England, GP at Hand, the digital-first…
Madison Alexander Wins Most Innovative PR firm for Infosec Companies; a Cybersecurity Excellence Award winner…
– Isaralgagene civaparvovec, or ST-920, continued to be generally well tolerated across three dose cohorts…
Yotta was awarded a grant from the California Energy Commission for a pilot system on…
Leading AI-powered platform provides global enterprises with the insights they need to manage costs, improve…
DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Logistics Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 –…
Research commissioned by Lenovo reveals CIOs are more involved than ever before in areas outside…
Ms. Wright Brings Extensive Global Digital Health, Regulatory and Legal Expertise SAN JOSE, Calif., Aug….
OK-101 to treat ocular diseases, including Dry Eye Disease (DED), uveitis, allergic conjunctivitis, and ocular…
FDA grants priority review to efanesoctocog alfa for people with hemophilia A The FDA decision…
Overall survival results from pooled exploratory analysis of MONALEESA trials in patients with aggressive HR+/HER2-…
PETALING JAYA, Malaysia, Aug 30, 2022 – (ACN Newswire) – Malaysian Genomics Resource Centre Berhad,…